InvestorsHub Logo
icon url

Couch

08/15/16 12:55 PM

#221875 RE: BostonTrader #221874

The original post was in regard to Nasrat shifting focus from SequestOx to the generic pipeline to obscure SequestOx's focus - which is FOS To begin with.

Nasrat continues to put SequestOx front and center.
icon url

DR Ryan

08/15/16 5:03 PM

#221913 RE: BostonTrader #221874

I would agree, the potential pipeline of ADT drugs getting approved is enormous.